Reducing postburn injury anemia in a Jehovah's Witness patient

J Burn Care Res. Jul-Aug 2014;35(4):e258-61. doi: 10.1097/BCR.0b013e3182a366c5.

Abstract

Anemia is a complication of severe burn injury. Burn patients who refuse blood transfusions, such as Jehovah's Witnesses, present difficult challenges, and treatment paradigms need to be altered to reduce blood loss and increase red cell restoration. In this report the authors present a case of a 36-year-old Jehovah's Witness who suffered a 35% TBSA burn injury. In addition to standard burn injury treatment, the authors attempted to reduce blood loss with a combination of intraoperative (tranexamic acid) and perioperative (erythropoietin, intravenous iron) strategies.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anemia / etiology
  • Anemia / prevention & control*
  • Antifibrinolytic Agents / therapeutic use
  • Blood Loss, Surgical / prevention & control
  • Burns / complications*
  • Burns / surgery
  • Erythropoietin / therapeutic use
  • Ferrous Compounds / therapeutic use
  • Hematinics / therapeutic use
  • Humans
  • Jehovah's Witnesses*
  • Male
  • Tranexamic Acid / therapeutic use

Substances

  • Antifibrinolytic Agents
  • Ferrous Compounds
  • Hematinics
  • Erythropoietin
  • Tranexamic Acid
  • ferrous gluconate